Clinical trials recruiting for Optic Neuritis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Clemastine | 1 |
| Efgartigimod Alfa | 1 |
| Methylprednisolone | 1 |
| Privosegtor | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| South Carolina | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- Efgartigimod for the Treatment of Acute Optic Neuritis
- Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis
- Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
- Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Related conditions
Trials recruiting for Optic Neuritis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Optic Neuritis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.